Office for Technology Commercialization
http://www.research.umn.edu/techcomm
612-624-0550

Acute Lymphoblastic Leukemia Cell Line and Mouse Model

Technology #20100059

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Collections
Image Gallery
Mouse Model Identifies Gene Required for LeukemiaCell Line Identifies Leukemia Cell Survival
Categories
Managed By
BJ Haun
Technology Licensing Officer

Acute Lymphoblastic Leukemia Cell Line and Mouse Model

The STAT5b-CA x pax5+/- leukemic cell line grows in the presence of interleukin-7. Withdrawal of IL7 results in cell death. We have also treated the STAT5b-CA x pax5+/- cell line with the histone deacetylase inhibitor apicidin. Cell line can be used to identify genes required for transformation and survival of the leukemic cells. Likewise, both the cell line and mouse model can be used to identify new drugs that might be efficacious against this form of leukemia; Activation of STAT5 can be observed in a high percentage (>35%) of adult ALL patients; likewise, mutations in pax5 have been found in >30% of human ALL patients. Thus, this model mimics one of the most common forms of leukemia.

PubMed ID# 21606506

MN-IP Try and Buy
MN-IP Try and Buy deal terms are in the process of being posted. Contact BJ Haun for specific details.